Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials

Detalles Bibliográficos
Autores principales: Chu, Xianjing, Tian, Wentao, Wang, Ziqi, Zhang, Jing, Zhou, Rongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294354/
https://www.ncbi.nlm.nih.gov/pubmed/37370104
http://dx.doi.org/10.1186/s12943-023-01812-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294354/
https://www.ncbi.nlm.nih.gov/pubmed/37370104
http://dx.doi.org/10.1186/s12943-023-01812-z

Ejemplares similares